Seven-time Tour de France winner Lance Armstrong says ‘Non merci’ to an offer that would clear his name of doping suspicions once and for all. The offer to retest Armstrong’s urine samples from 1999 Tour de France came from Pierre Bordry, head of French anti-doping agency.
From Cycling Weekly:
Bordry yesterday offered to retest the samples according to L’Equipe newspaper as of a way to prove Armstrong’s good faith and dispel accusations made by the L’Equipe newspaper that the samples may contain traces of the banned blood booster EPO.
It was L’Equipe which broke the news back in 2005 that six of Armstrong’s urine samples from the 1999 Tour allegedly showed traces of the banned compound erythropoietin (EPO) in an article entitled “The Armstrong Lie.”
Armstrong vehemently denied the allegation with this statement:
“Unfortunately, the witch hunt continues and tomorrow’s article is nothing short of tabloid journalism,” Armstrong wrote on his Web site. “I will simply restate what I have said many times: I have never taken performance-enhancing drugs.”
In a written statement, Armstrong sidestepped the offer by claiming that an independent investigation instigated by the UCI had said the 1999 samples “have not been maintained properly, have been compromised in many ways, and even three years ago could not be tested to provide any meaningful results.”
“There is simply nothing that I can agree to that would provide any relevant evidence about 1999,” Armstrong added in his statement.
Armstrong also pointed out that the “the Independent Investigation concluded that the French laboratory, the French Ministry of Sport, and Dick Pound, the former head of the World Anti-Doping Agency, all behaved improperly with respect to the 1999 Tour de France samples.”
He says that WADA and the French Ministry refused to address the finding of the investigation by refusing to have the issues heard by the Court of Arbitration for Sport.
“If Mr. Bordry would now like to re-examine the past, he must start with presenting the issues of the misconduct of the French laboratory, the French Ministry, and WADA before a proper tribunal.” Armstrong said in the statement.
The seven-time Tour de France winner also reminded everyone that he has agreed to work with anti-doping expert Dr Don Catlin for his comeback to racing, to develop a blood and urine testing protocol. Armstrong said that his results will be posted on the internet and that the testing protocol will be available to other riders.
At the time the said samples were taken, there were no means to determine the presence of exogenous EPO. The samples were preserved and have undergone testing again by a French lab located near Paris. However, doubts surround the validity of the tests conducted by the French lab since they were taken on B samples only since the A samples have already been used up.
EPO enhances performance by increasing red blood cell production. Clinically, EPO is used to treat certain types of anemia, particularly those that are due to chronic kidney disease and from treatment of cancer. EPO is sometimes referred to as Erythropoiesis Stimulating Agent or ESA when used as performance-enhancing drug.
EPO and related substances, along with anabolic-androgenic steroids and their related substances, are included in the World Anti-Doping Agency’s list of prohibited substances. According to WADA, “unless the athlete can demonstrate that the concentration (of prohibited substance) was due to physiological or pathological condition” and “if a laboratory report, using a reliable analytical method, that the Prohibited Substance is of exogenous origin, the Sample will be deemed to contain a Prohibited Substance and shall be reported as an Adverse Analytical Finding.”
Tags: anabolic-androgenic steroids, doping, EPO, Lance Armstrong, Pierre Bordry, steroids, Tour de France, World Anti-Doping Agency
Posted in steroid nation, Steroids and Anabolic Steroids, Steroids in Olympics